REESE DAVID M
SEC CIK 1748434 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AMGN | Amgen | EVP, Research, Development | 42.3K | — | $10.23M | 35 | 2021-11-02 | 2026-05-07 |
Most active insiders at AMGN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Santos Esteban | EVP, Ops | — | $20.77M |
| 2 | Grygiel Nancy A. | SVP, CCO | — | $2.65M |
| 3 | Gordon Murdo | EVP, Gbl Commercial Ops | — | $2.32M |
| 4 | Khosla Rachna | SVP, Business Development | — | $1.65M |
| 5 | Miller Derek | SVP, Human Resources | — | $1.57M |
| 6 | Busch Matthew C. | VP, CAO, Fin | — | $375.8K |
| 7 | Klotman Mary E. | Dir | — | — |
| 8 | Bradner James E. | EVP, Research, Development | — | — |
| 9 | Drake Michael V | Dir | — | — |
| 10 | Griffith Peter H. | EVP, CFO | — | — |
| 11 | REESE DAVID M | EVP, CTO | — | — |
Transactions 35
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-11 20:07 | 2026-05-07 | AMGN | Amgen | REESE DAVID M | EVP, CTO | F - Tax | $331.11 | -556 | 42.3K | -1% | -$184.1K | |
| D | 2026-05-07 20:48 | 2026-05-05 | AMGN | Amgen | REESE DAVID M | EVP, CTO | A - Grant | $0.00 | +2,912 | 43.3K | +7% | $0 |
| D | 2026-05-07 20:48 | 2026-05-06 | AMGN | Amgen | REESE DAVID M | EVP, CTO | F - Tax | $329.59 | -454 | 42.8K | -1% | -$149.6K |
| M | 2026-05-05 20:12 | 2026-05-02 | AMGN | Amgen | REESE DAVID M | EVP, CTO | F - Tax | $329.82 | -1,433 | 40.4K | -3% | -$472.6K |
| 2026-03-18 | 2026-03-16 | AMGN | Amgen | REESE DAVID M | EVP, CTO | F - Tax | $366.21 | -6,022 | 41.8K | -13% | -$2.21M | |
| 2026-03-05 | 2026-03-03 | AMGN | Amgen | REESE DAVID M | EVP, CTO | A - Grant | $0.00 | +12.1K | 47.6K | +34% | $0 | |
| M | 2025-11-12 | 2025-11-11+ | AMGN | Amgen | REESE DAVID M | EVP, CTO | G - Gift | $0.00 | -6,799 | 35.8K | -16% | $0 |
| D | 2025-05-08 | 2025-05-06 | AMGN | Amgen | REESE DAVID M | EVP, CTO | A - Grant | $0.00 | +3,549 | 42.1K | +9% | $0 |
| M | 2025-05-06 | 2025-05-02 | AMGN | Amgen | REESE DAVID M | EVP, CTO | F - Tax | $283.78 | -1,367 | 38.6K | -3% | -$387.9K |
| 2025-05-02 | 2025-04-30 | AMGN | Amgen | REESE DAVID M | EVP, CTO | F - Tax | $288.56 | -768 | 39.9K | -2% | -$221.6K | |
| 2025-03-19 | 2025-03-17 | AMGN | Amgen | REESE DAVID M | EVP, CTO | F - Tax | $313.71 | -3,635 | 40.7K | -8% | -$1.14M | |
| 2025-03-05 | 2025-03-03 | AMGN | Amgen | REESE DAVID M | EVP, CTO | A - Grant | $0.00 | +7,277 | 44.2K | +20% | $0 | |
| D | 2025-02-21 | 2025-02-19 | AMGN | Amgen | REESE DAVID M | EVP, CTO | M - OptEx | $156.35 | +8,711 | 70.9K | +14% | +$1.36M |
| DM | 2025-02-21 | 2025-02-19+ | AMGN | Amgen | REESE DAVID M | EVP, CTO | S - Sale+OE | $301.56 | -33.9K | 36.9K | -48% | -$10.23M |
| D | 2024-05-09 | 2024-05-07 | AMGN | Amgen | REESE DAVID M | EVP, CTO | A - Grant | $0.00 | +3,196 | 61.9K | +5% | $0 |
| 2024-05-07 | 2024-05-05 | AMGN | Amgen | REESE DAVID M | EVP, CTO | F - Tax | $311.29 | -633 | 58.7K | -1% | -$197.0K | |
| 2024-05-03 | 2024-05-02 | AMGN | Amgen | REESE DAVID M | EVP, CTO | F - Tax | $277.37 | -650 | 59.3K | -1% | -$180.3K | |
| 2024-05-01 | 2024-04-30 | AMGN | Amgen | REESE DAVID M | EVP, CTO | F - Tax | $276.38 | -690 | 60.0K | -1% | -$190.7K | |
| 2024-03-20 | 2024-03-18 | AMGN | Amgen | REESE DAVID M | EVP, CTO | F - Tax | $268.87 | -6,202 | 60.7K | -9% | -$1.67M | |
| 2024-03-08 | 2024-03-06 | AMGN | Amgen | REESE DAVID M | EVP, CTO | A - Grant | $0.00 | +12.4K | 66.7K | +23% | $0 | |
| 2023-11-29 | 2023-11-28 | AMGN | Amgen | REESE DAVID M | EVP, Research, Development | G - Gift | $0.00 | -165 | 54.2K | -0.3% | $0 | |
| 2023-05-09 | 2023-05-05 | AMGN | Amgen | REESE DAVID M | EVP, Research, Development | F - Tax | $231.89 | -594 | 54.1K | -1% | -$137.7K | |
| D | 2023-05-04 | 2023-05-02 | AMGN | Amgen | REESE DAVID M | EVP, Research, Development | A - Grant | $0.00 | +3,814 | 55.5K | +7% | $0 |
| D | 2023-05-04 | 2023-05-03 | AMGN | Amgen | REESE DAVID M | EVP, Research, Development | F - Tax | $235.97 | -819 | 54.7K | -1% | -$193.3K |
| 2023-05-02 | 2023-04-30 | AMGN | Amgen | REESE DAVID M | EVP, Research, Development | F - Tax | $239.74 | -666 | 51.7K | -1% | -$159.7K | |
| 2023-03-20 | 2023-03-17 | AMGN | Amgen | REESE DAVID M | EVP, Research, Development | F - Tax | $234.57 | -3,978 | 52.4K | -7% | -$933.1K | |
| 2023-03-08 | 2023-03-06 | AMGN | Amgen | REESE DAVID M | EVP, Research, Development | A - Grant | $0.00 | +7,947 | 56.2K | +16% | $0 | |
| 2022-11-03 | 2022-11-02 | AMGN | Amgen | REESE DAVID M | EVP, Research, Development | F - Tax | $272.06 | -2,440 | 48.1K | -5% | -$663.8K | |
| 2022-05-09 | 2022-05-05 | AMGN | Amgen | REESE DAVID M | EVP, Research, Development | F - Tax | $236.10 | -575 | 50.3K | -1% | -$135.8K | |
| D | 2022-05-04 | 2022-05-02 | AMGN | Amgen | REESE DAVID M | EVP, Research, Development | A - Grant | $0.00 | +3,897 | 51.7K | +8% | $0 |
| D | 2022-05-04 | 2022-05-03 | AMGN | Amgen | REESE DAVID M | EVP, Research, Development | F - Tax | $230.92 | -770 | 50.9K | -1% | -$177.8K |
| 2022-04-29 | 2022-04-27 | AMGN | Amgen | REESE DAVID M | EVP, Research, Development | F - Tax | $249.87 | -184 | 47.8K | -0.4% | -$46.0K | |
| 2022-03-22 | 2022-03-18 | AMGN | Amgen | REESE DAVID M | EVP, Research, Development | F - Tax | $235.86 | -4,995 | 47.9K | -9% | -$1.18M | |
| 2022-03-03 | 2022-03-01 | AMGN | Amgen | REESE DAVID M | EVP, Research, Development | A - Grant | $0.00 | +9,989 | 52.7K | +23% | $0 | |
| 2021-11-03 | 2021-11-02 | AMGN | Amgen | REESE DAVID M | EVP, Research, Development | F - Tax | $209.74 | -2,192 | 42.6K | -5% | -$459.8K |
Purchase Sale Sale after option exercise All abbreviations